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ABSTRACT 
ADHD is one of the most prevalent neurodevelopmental 
disorder.	Antioxidant concentrations are shifted in ADHD 
patients and antioxidant centred therapies appear to 
alleviate symptoms significantly1-8. This study aims to 
investigate antioxidant concentrations in children with 
ADHD of an Antwerp based population. 
For the ADHD-cohort, concentrations of lipid-soluble 
antioxidants (a-tocopherol, g-tocopherol, retinyl-
palmitate, b-carotene, CoQ10 and retinol) (plasma, n = 12) 
and glutathione (erythrocytes, n = 4) were measured and 
consecutively compared to a cohort of non-ADHD 
children (n = 25-53). Additionally, differences in mean 
concentrations were compared to literature1,7,8.  
Keywords 
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INTRODUCTION 
ADHD is the most common neurodevelopmental disorder 
diagnosed in children. Most patients are diagnosed during 
their early school years. Because ADHD patients often 
experience impairments in academic or work performance 
and moreover face social challenges, diagnosis and 
treatment are of high importance. Diagnostic criteria are 
stated in the Diagnostic and Statistical Manual of 
Psychological Disorders (DSM).	ADHD is described as 
“a persistent pattern of inattention and/or hyperactivity-
impulsivity that interferes with functioning or 
development”9.		
Clinical tests along with questionnaires are 
recommended10. However, no biological markers have 
been accepted as diagnostic for ADHD yet.  
To date, understanding of the aetiology is not definite and 
diagnostic methods in particular for children are often 
vague. In recent years, oxidative stress (OS) in the 
pathogenesis of ADHD gained interest. 	
OS is defined as a shift in the biological balance of oxidant 
production and antioxidants, towards an oxidant excess. 
OS is utilised in redox regulation, in either redox-
signalling or redox-control. Redox regulations involve 
pro-oxidants (free-radicals species and non-radical 
species), antioxidants (enzymes and low-molecular mass 
compounds) and molecular targets of great diversity.  
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In living organisms, all redox regulations are tightly 
controlled on an individual and a network level. This tight 
control creates a steady state, the redox homeostasis.11  
The redox homeostasis is defined by the Redox Code12 and 
describes, how redox regulations are balanced. 	
While the brain is a major oxygen metabolizer, depending 
on constant oxygen supply, it has only limited protective 
mechanisms against OS13. The high proportions of 
peroxidizable PUFAs and iron levels, present in the brain 
matter, are an additional risk. The brain is therefore more 
susceptible to damage due to OS than other organs14. 
Studies on biomarkers of OS in ADHD do help to gain 
better insights into ADHD’s pathogenesis and hold 
promising diagnostic values.  
Studies on the effects of antioxidant based treatments, 
suggest that OS is implemented in the ADHD 
pathogenesis. Dietary studies in children with ADHD 
support the key-role of OS in ADHD. Exogenous 
antioxidants and foods balancing out the oxidative 
dyshomeostasis appear to successfully alleviate 
symptoms4-6. If symptoms are altered through 
manipulations of a patient’s oxidative homeostasis, 
neurochemical imbalances such as synaptic spill overs or 
hyper-catecholaminergic states might theoretically be 
altered accordingly. Recently, Hellmer and Nyström found 
that neurochemical imbalances are detectable prior to 
ADHD manifestations15. It is therefore of great importance 
to gain better understanding of the development of these 
neurochemical imbalances. By correcting or preventing a 
dysbalanced neurochemistry, children would potentially 
not have to experience ADHD symptoms and be effected 
by such throughout their life time.  
Of great interest are antioxidant concentrations and status 
in children with ADHD, as these might provide 
approachable therapy targets. 
 
Gluthatione (GSH) 
GSH is an important intracellular antioxidant, known to 
protect proteins and cell membranes from oxidative 
damage. Two GSH can be oxidised to glutathione 
disulphide (GSSG). In normal cell oxidation metabolism, 
GSH outnumbers GSSG16. GSSG has cytotoxic potential17 
and might react with protein thiols resulting in the 
production of a protein mixed disulphide (PSSG) during 
oxidative stress18. In plasma of children with ADHD, 
Ceylan et al. found low levels of GSH-Peroxidase19, 
whereas Simsek et al. did not find different concentrations 
in comparison to control8. The findings  
of Ceylan et al. might present a shift in the homeostasis of 
GSH and GSSG away from the antioxidant protection of 
GSH. Similar findings were concluded from animal 
studies20,21. However, such animal studies should be  
 
 
 
interpreted carefully because of limited comparability with 
human studies. The ratio of GSH to GSSG can be 
indicative of oxidative dyshomeostasis. Dvorakova et al. 
found GSH/GSSG to be decreased in paediatric ADHD 
patients and saw increases in this ratio after treatment with 
an antioxidant-modulatory pine-bark extract called 
Pycnogenolâ2,22.  
 
Figure 1. GSH/GSSG metabolism 
Lipid-soluble antioxidants 
Certain vitamins are known for neuroprotective effects due 
to antioxidant properties. This idea is supported by 
findings in a rat-study23. A small number of vitamins were 
chosen as biomarkers to investigate OS in ADHD to date. 
In paediatric cohorts, only vitamin A and E have been 
studied yet. Studies on OS in adult ADHD cohorts studied 
different vitamins and found increased concentrations of 
folate24 and ascorbate25, but no differences for vitamin 
B625 and B1224 These vitamin concentrations need to be 
investigated in children yet. Vitamin E (a- and g-
tocopherol) is known to reduce lipid hydroxyl radicals and 
lipid peroxides, originating from polyunsaturated fatty 
acids (PUFAs). PUFAs are a dominant constituent of the 
brain. Vitamin E is also linked to GSH via vitamin C 
reduction and storage17. Vitamin E concentrations were 
found to be increased in paediatric ADHD patients7. 
Besides vitamin E, vitamin A (b-carotene, retinol and 
retinylpalmitate) has also shown some neuroprotective 
effect23. Vitamin A however did not present abnormal 
concentrations in the yet only paediatric ADHD patient-
cohort studied7. Co-enzyme Q10 (CoQ10) is a lipophilic 
antioxidant with potentially OS-combating capacities26.  
 
METHODS 
For a trial run by the NaTuRA research group at the 
University of Antwerp, the effect of pycogenol on ADHD 
in comparison to methylphenidate or placebo were 
investigated in a randomized, double-blinded, three-armed 
set-up. Blood, urine and stool samples from children with 
ADHD were collected at the University hospital Antwerp 
from all treatment-cohorts at both baseline and after ten 
weeks of treatment.27  
A small number of baseline samples was selected 
randomly for the here reported research. Using High 
Pressure Liquid Chromatography (HPLC), the 
concentrations of lipid-soluble antioxidants in 24 plasma 
samples and GSH concentrations in four red blood cells 
(RBC) samples were determined. 
Analysis of lipid-soluble antioxidant concentrations 
Plasma concentrations for the following lipid-soluble 
antioxidant were determined: retinol, a-tocopherol, g-
tocopherol, retinylpalmitate, b-carotene and CoQ10. After  
extracting these lipid-soluble compounds from the plasma 
samples with hexane, Reversed-phase High Pressure 
Liquid Chromatography (RP-HPLC) combined with  
electrochemical detectors were utilized to create a  
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chromatogram. The antioxidants, were separated during 
RP-HPLC while migrating through an ODS Hypersil (150 
x 3 mm; 3 µm) column. A solution of methanol:milliQ:1M 
ammonium acetate (90:8:2) and a solution of methanol:1-
propanol:1M ammonium acetate (78:20:2) were used as 
mobile phases A and B respectively. Hereby a separation 
based on solubility was yielded. For each of the twelve 
children, a mean was calculated from the respective duplo 
measurements. A mean for the ADHD cohort was 
calculated in µg/ml and µmol/L.  
Analysis of GSH concentrations 
GSH concentrations were determined using RBCs. 
Following precipitation and centrifugation, normal-phase 
HPLC combined with electrochemical detectors created a 
chromatogram.	 The detection cell potentials were 500, 
580, 660, 740, 820, 900, 980, 1060 and mV. For the 
extraction of GSH during HPLC, two mobile phases were 
utilized. Mobile phase A was a solution of 25 mM 
NaH2PO4.2H2O, 1.4 mM OSA and 3% methanol. Mobile 
phase B was a solution of 25 mM NaH2PO4.2H2O, 1.4 
mM Octanesulfonic acid (OSA) and 50% methanol. A RP-
18 endcapped column (250 x 4.8 mm; 5 µm) was utilized. 
The mean GSH concentration in µmol/L at baseline was 
calculated.		
Comperative analysis	
No standard reference concentrations for either the lipid 
soluble antioxidants or GSH are established. The trial 
design does not include a N-ADHD control. The resulting 
concentrations were therefore compared to mean 
concentrations of a non-ADHD cohort of a previous study 
at NatuRA. In the previous study, concentrations of 
retinol, a-tocopherol, g-tocopherol, b-carotene, CoQ10 
and GSH were measured in equivalent manners in a N-
ADHD cohort selected from the same population. No 
comparison was possible for retinylpalmitate. IBM SPPS 
25 Statistics and Excel were utilized to assist the 
comparison of concentrations via descriptive statistics. 
Relative differences between mean-concentrations were 
assessed. As the ADHD cohort is comparatively smaller 
than the N-ADHD cohort, Mann-Whitney testing was 
selected to test for significant differences between the 
concentrations. As the Mann-Whitney test implies the 
assumption that the concentrations of the two cohorts are 
distributed equally, homogeneity of variance was tested. 
Additionally, these outcomes were compared to literature.  
 
RESULTS 
ADHD vs. N-ADHD mean concentrations 
The mean concentrations of the individual antioxidants 
were compared by means of relative differences (%), given 
in table 1 and discussed below. 
The mean concentration of four lipid-soluble antioxidants 
(𝛼-tocopherol, 𝛾-tocopherol, 𝛽-carotene, CoQ10) appear 
to be increased in the ADHD-samples in comparison to the 
N-ADHD control. The mean concentrations for retinol 
differed only slightly. The mean concentration of GSH for 
the ADHD cohort at baseline did not differ significantly 
from the N-ADHD cohort.  
Outcomes of Mann-Whitney test  
The differences between the medians of all but glutathione 
are significant in that the respective significances (p) are 
smaller than 0.001. For glutathione, the concentration of 
the ADHD cohort (median 2.350) did not differ  
 
 
significantly from the N-ADHD cohort (median 2.070), 
U = 73.000, z = -1.03, p = 0.323, r = - 0.137.  
Significances of the Levene statistics indicate that the 
concentrations of the two cohorts are not distributed 
equally for retinol F(1,21.126) = 0.466, p = 0.502 and 
glutathione F(1,35.615) = 1.729, p = 0.197.  
The concentrations of all other antioxidants are distributed 
equally according to the Leven test:  α-tocopherol F(1,19.753) = 12.015, p = 0.002,  γ-tocopherol F(1,17.900) = 26.502, p = 0.000,  β-carotene F(1,12.286) = 12.105, p = 0.004 and  
CoQ10 F(1,12.681) = 19.152, p = 0.001 
Differences between the concentrations of the two 
cohorts compared to literature 
Spahis et al. found concentrations of a-tocopherol and g-
tocopherol to be increased in their ADHD-cohort, as well7. 
They did not see differences in their retinol concentrations 
though7. Contrary to the above-mentioned outcomes, 
Simsek et al. found no significant difference in CoQ10 
concentrations in their study8 and Spahis et al. found no 
differences in b-carotene concentrations7. 
In their study on the effects of Pycnogenolâ on OS in 
ADHD children, Dvořáková et al. found that GSH 
concentrations increase with Pycnogenolâ treatment, 
while GSSG concentrations decrease2. No indications 
were made, whether GSH concentrations were elevated at 
baseline. To date, no studies on GSH concentrations in  
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ADHD children compared to neurotypical children have 
been published.  
 
DISCUSSION 
Differences in concentrations of some compounds of 
interest were found. This might indicate a shift in oxidative 
homeostasis, as proposed by various studies investigating 
OS in ADHD, to be present in ADHD patients. However  
due to certain limitations, the above given results should 
be interpreted with care.  
While a Mann-Whitney tests assumes that the data of two 
cohorts is distributed in an equivalent manner, this is not 
the case for glutathione. The respective p-value should 
therefore not be taken into account, when comparing the 
medians of glutathione of the two cohorts.  
Biomarkers need to be specific. The here investigated 
lipid-soluble antioxidants are not brain or ADHD specific. 
Elevated concentrations might point to increased OS 
occurrence though. OS in this case needs to be generalized 
unless proven ADHD-specific by additional biomarkers.  
While the GSH/GSSG ratio might be indicative of an 
oxidative dyshomeostasis, GSH by itself cannot be. 
Therefore, correlations between GSH and the vitamin E 
might be interesting to explore.  
The here discussed compounds might not be diagnostic 
biomarkers for ADHD in children. The concentrations of 
these compounds in comparison to neurotypical controls, 
however, could be of value in understanding the ADHD 
pathophysiology. As proposed by Kul et al., antioxidants 
might only insufficiently combat OS in children with 
ADHD28 Alternative treatments such as Pycogenolâ or 
dietary regulation, increase antioxidant concentrations and 
alleviate ADHD symptoms. This underlines the 
importance of antioxidants in ADHD treatment.  
 
Limitations 
The number of samples analysed and discussed in this 
bachelor thesis is small. Therefore, the results lack power 
and might be prone to clustering illusion and/or 
insensitivity to sample size. As the control concentrations 
were obtained as part of a separate study, one cannot be 
sure that the ADHD cohort and control cohort are 
comparable. This might bias the outcomes. To date, only 
two studies have been looking into the here discussed 
biomarkers in children. Two studies have been 
investigating GSH concentrations in ADHD-animal 
models with contrary outcomes20,21. The comparability of 
animal and human studies in neurodevelopmental 
disorders is limited though. While retinol, a-tocopherol, 
g-tocopherol, b-carotene, CoQ10 and GSH are known to 
have neuroprotective effects, they also play important 
roles in other physiological functions.  
 
 
	
 
Table 1. Sample sizes (N), mean concentrations and standard deviation (SD) for both the ADHD and N-ADHD cohort as 
well as the relative differences (∆%) between the two cohorts for each of the measured antioxidant.  
Medians of concentrations of both cohorts for each measured antioxidant.  
Mann-Whitney test results: test statistic (U) with corresponding z-score (z), effect size (r) and significance. 
 
	
Figure 2. Medians of concentrations of 𝜸-tocopherol, 
retinol, 𝜷-carotene, CoQ10 and GSH 
	
Figure 3. Medians of concentrations of 𝜶-tocopherol 
Plasma samples or RBC samples are therefore 
representative of the overall oxidative balance, not limited 
to the brain. In particular, in paediatric ADHD patients a 
distinction between peripheral OS and brain centred OS is 
of importance due  
to hyperkinesis29,30. 
 
CONCLUSION 
Most of the antioxidant concentrations investigated, 
appear to be elevated in the ADHD cohort. Due to the 
limitations discussed above, this observation should be 
tested for reproducibility by future studies including 
controls. The antioxidants discussed here, are unlikely to 
become diagnostic biomarkers of ADHD. GSH included in 
the GSH/GSSG ratio could, however, play an important 
role as biomarker for OS. The importance of oxidative 
balance and antioxidants in ADHD is highlighted by the 
findings of the literature study and ascertained by the 
outcomes of the investigations.  
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